Clinical Trial: A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Hepatocellular Carcinoma (HCC)
Study Type: INTERVENTIONAL
Official Title: An Open-label Phase 1 Imaging Study to Evaluate the Biodistribution, Dosimetry, Safety and Pharmacokinetics of BAY 3630942, a 89Zr-labeled Monoclonal Antibody, With a Pre-infusion of BAY 3547922, a Mo
Brief Summary:
Researchers are studying a new potential treatment for liver cancer or other select solid cancers.To do this, researchers have developed a protein, called a monoclonal antibody, which can find and attach itself to another protein present on the surface of cancer cells.This can help the new treatment to specifically target cancer cells.In this study, researchers want to understand the distribution and processing of this monoclonal antibody in people with liver cancer or other select solid cancers.Researchers will…
Read more